DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Baselga J, Carbonell X, Castañeda-Soto NJ et al.
Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule.
J Clin Oncol 2005;
23 (10) 2162-2171
We do not assume any responsibility for the contents of the web pages of other providers.